Lannett Company, Inc.
(NYSE : LCI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
2.13%43.040.9%$1173.72m
LLYEli Lilly and Company
1.25%124.251.0%$1055.34m
JNJJohnson & Johnson
0.71%136.380.6%$990.30m
MRKMerck & Co., Inc.
1.04%80.660.6%$958.22m
BMYBristol-Myers Squibb Company
1.24%50.751.4%$778.59m
ABBVAbbVie, Inc.
1.27%79.752.2%$664.84m
AZNAstraZeneca PLC Sponsored ADR
0.97%40.821.3%$195.02m
NVSNovartis AG Sponsored ADR
0.28%90.760.2%$187.41m
GSKGlaxoSmithKline plc Sponsored ADR
-0.11%40.500.2%$136.44m
NVONovo Nordisk A/S Sponsored ADR Class B
0.23%49.780.1%$70.39m
SNYSanofi Sponsored ADR
-0.29%41.210.2%$36.75m
LCILannett Company, Inc.
2.19%9.5636.7%$16.79m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.54%1.841.7%$0.06m
EPIXESSA Pharma Inc
5.13%3.750.1%$0.05m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escitalopram oxalate; ranitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.